chr19-36877492-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001242472.2(ZNF345):c.662G>A(p.Arg221Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,611,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001242472.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF345 | NM_001242472.2 | c.662G>A | p.Arg221Gln | missense_variant | 3/3 | ENST00000420450.6 | NP_001229401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF345 | ENST00000420450.6 | c.662G>A | p.Arg221Gln | missense_variant | 3/3 | 1 | NM_001242472.2 | ENSP00000431216 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000333 AC: 5AN: 150038Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251020Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135638
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461840Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727216
GnomAD4 genome AF: 0.0000333 AC: 5AN: 150038Hom.: 0 Cov.: 33 AF XY: 0.0000273 AC XY: 2AN XY: 73282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.662G>A (p.R221Q) alteration is located in exon 3 (coding exon 1) of the ZNF345 gene. This alteration results from a G to A substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at